-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, WqCil6lA/uTH+q4gvied7ONCeKUsMIRp8YqtsvTza5jlStenuP6mtdmqWYNvh45s On9RykSzAHDZWjtZWOZGLw== 0000927653-97-000014.txt : 19970612 0000927653-97-000014.hdr.sgml : 19970612 ACCESSION NUMBER: 0000927653-97-000014 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 19960930 FILED AS OF DATE: 19970606 DATE AS OF CHANGE: 19970611 SROS: NYSE SROS: PSE FILER: COMPANY DATA: COMPANY CONFORMED NAME: MCKESSON CORP CENTRAL INDEX KEY: 0000927653 STANDARD INDUSTRIAL CLASSIFICATION: 5122 IRS NUMBER: 943207296 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-13252 FILM NUMBER: 97620584 BUSINESS ADDRESS: STREET 1: ONE POST ST CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 4159838300 FORMER COMPANY: FORMER CONFORMED NAME: SP VENTURES INC DATE OF NAME CHANGE: 19940728 10-Q/A 1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 2) (Mark One) [ X ] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For quarter ended September 30, 1996 [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ------------ ------------ Commission file number 1-13252 ------- McKESSON CORPORATION - - ----------------------------------------------------------------- (Exact name of Registrant as specified in its charter) DELAWARE 94-3207296 - - ------------------------------- ------------------- (State or other jurisdiction of (IRS Employer incorporation or organization) Identification No.) One Post Street, San Francisco, California 94104 - - ----------------------------------------------------------------- (Address of principal executive offices) (Zip Code) - - ------------------------------------------------------------- (415) 983-8300 - - ----------------------------------------------------------------- (Registrant's telephone number, including area code) Indicate by check mark whether the Registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes X No ----- ----- Indicate the number of shares outstanding of each of the issuer's classes of common stock, as of the latest practicable date. Class Outstanding at September 30, 1996 - - ---------------------------- --------------------------------- Common stock, $.01 par value 41,941,126 shares The Registrant hereby amends the items, financial statements, exhibits, or other portions of its Quarterly Report on Form 10-Q for the quarter ended September 30, 1996 as set forth below. LIST OF ITEMS AMENDED PART I. FINANCIAL INFORMATION ============================== Item Page - - ---- ---- 1. Condensed Financial Statements Consolidated Balance Sheets September 30, 1996 and March 31, 1996 3 - 4 Statements of Consolidated Income Three and Six month periods ended September 30, 1996 and 1995 5 Statements of Consolidated Cash Flows Three and Six month periods ended September 30, 1996 and 1995 6 - 7 Financial Notes 8 - 9 2. Management's Discussion and Analysis of Financial Condition and Results of Operations Financial Review 10 - 12 PART II. OTHER INFORMATION =========================== 6. Exhibits and Reports on Form 8-K 13 Exhibit Index 15 TEXT OF ITEMS AMENDED Each of the above listed Items is hereby amended by deleting the Item in its entirety and replacing it with the Items attached hereto and filed herewith. The purpose of this amendment is to reflect, in the first quarter ended June 30, 1996, the $48.2 million charge to write off the portion of the purchase price of Automated Healthcare, Inc. ("AHI") allocated to technology for which feasibility had not been established as of the acquisition date of April 23, 1996. Such charge was recorded in the third quarter ended December 31, 1996 in the originally filed financial statements. PART I. FINANCIAL INFORMATION =============================== McKESSON CORPORATION and SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Restated (unaudited) September 30, March 31, 1996 1996 ------ ------ (in millions) ASSETS - - ------ Current Assets Cash and cash equivalents $ 133.3 $ 260.8 Marketable securities available for sale 57.0 195.4 Receivables 933.0 672.8 Inventories 1,283.8 1,317.0 Prepaid expenses and other 26.2 17.0 ------- ------- Total 2,433.3 2,463.0 ------- ------- Property, Plant and Equipment Land 37.9 38.0 Buildings, machinery and equipment 709.0 675.7 ------- ------- Total 746.9 713.7 Accumulated depreciation (380.2) (357.7) ------- ------- Net 366.7 356.0 Goodwill and other intangibles 192.5 183.7 Net assets of discontinued operations (Note 3) 121.1 125.7 Other assets 271.9 231.8 ------- ------- Total Assets $3,385.5 $3,360.2 ======= ======= (Continued) - 3 - McKESSON CORPORATION and SUBSIDIARIES CONSOLIDATED BALANCE SHEETS Restated (unaudited) September 30, March 31, 1996 1996 ------ ------ (in millions) LIABILITIES AND STOCKHOLDERS' EQUITY - - ------------------------------------ Current Liabilities Drafts payable $ 240.2 $ 194.0 Accounts payable - trade 1,176.1 1,149.2 Short-term borrowings 95.0 6.6 Current portion of long-term debt 23.8 27.9 Salaries and wages 27.1 26.3 Taxes 100.3 92.2 Interest and dividends 18.5 19.0 Other 122.6 127.3 ------- ------- Total 1,803.6 1,642.5 ------- ------- Postretirement Obligations and Other Noncurrent Liabilities 212.7 216.6 ------- ------- Long-Term Debt 439.5 436.5 ------- ------- Stockholders' Equity Common stock 0.4 0.4 Additional paid-in capital 330.9 332.0 Other capital (37.6) (36.2) Retained earnings 959.2 968.9 Accumulated translation adjustment (42.8) (49.7) ESOP notes and guarantee (120.2) (122.5) Treasury shares, at cost (160.2) (28.3) ------- ------- Net 929.7 1,064.6 ------- ------- Total Liabilities and Stockholders' Equity $3,385.5 $3,360.2 ======= ======= See Financial Notes. (Concluded) - 4 - McKESSON CORPORATION and SUBSIDIARIES STATEMENTS OF CONSOLIDATED INCOME Restated (unaudited) Three Months Ended Six Months Ended September 30 September 30 --------------- --------------- 1996 1995 1996 1995 ------ ------ ------ ------ (in millions - except per share amounts) REVENUES $2,730.9 $2,402.6 $5,401.5 $4,790.9 ------- ------- ------- ------- COSTS AND EXPENSES Cost of sales 2,499.9 2,173.3 4,938.6 4,340.4 Selling, distribution and administration 179.0 171.4 356.5 333.9 Purchased in-process technology (Note 2) - - 48.2 - Interest 10.2 11.5 21.1 23.2 ------- ------- ------- ------- Total 2,689.1 2,356.2 5,364.4 4,697.5 ------- ------- ------- ------- INCOME BEFORE TAXES ON INCOME 41.8 46.4 37.1 93.4 TAXES ON INCOME (16.0) (18.2) (32.7) (37.2) ------- ------- ------- ------- INCOME AFTER TAXES Continuing operations 25.8 28.2 4.4 56.2 Discontinued operations (Note 3) 2.3 3.5 5.6 8.3 ------- ------- ------- ------- NET INCOME $ 28.1 $ 31.7 $ 10.0 $ 64.5 ======= ======= ======= ======= EARNINGS PER COMMON SHARE Fully diluted earnings Continuing operations $ 0.59 $ 0.61 $ 0.10 $ 1.21 Discontinued operations 0.05 0.07 0.12 0.17 ------- ------- ------- ------- Total $ 0.64 $ 0.68 $ 0.22 $ 1.38 ======= ======= ======= ======= Primary earnings Continuing operations $ 0.59 $ 0.61 $ 0.10 $ 1.21 Discontinued operations 0.05 0.07 0.12 0.17 ------- ------- ------- ------- Total $ 0.64 $ 0.68 $ 0.22 $ 1.38 ======= ======= ======= ======= Dividends $ 0.25 $ 0.25 $ 0.50 $ 0.50 ======= ======= ======= ======= SHARES ON WHICH EARNINGS PER COMMON SHARE WERE BASED Fully diluted 43.8 46.7 44.6 46.8 Primary 43.8 46.7 44.6 46.7 See Financial Notes. - 5 - McKESSON CORPORATION and SUBSIDIARIES STATEMENTS OF CONSOLIDATED CASH FLOWS Restated (unaudited) Six Months Ended September 30 ------------------ 1996 1995 ------ ------ (in millions) Operating Activities Income from continuing operations $ 4.4 $ 56.2 Adjustments to reconcile to net cash provided (used) by operating activities Depreciation 31.3 27.5 Amortization 4.9 3.5 Provision for receivables reserves 3.6 4.6 Deferred taxes on income 2.0 (5.5) Gain on sale of subsidiary - (11.2) Other non-cash items (Note 2) 45.9 (1.3) ------- ------- Total 92.1 73.8 ------- ------- Effects of changes in Receivables (256.3) (96.4) Inventories 35.1 48.1 Accounts and drafts payable 74.1 113.5 Taxes 17.1 (55.5) Other (27.5) (79.2) ------- ------- Total (157.5) (69.5) ------- ------- Net cash provided (used) by continuing operations (65.4) 4.3 ------- ------- Discontinued operations 9.0 21.8 ------- ------- Net cash provided (used) by operating activities (56.4) 26.1 ------- ------- Investing Activities Purchases of marketable securities (0.2) (130.3) Maturities of marketable securities 141.8 49.9 Property acquisitions (41.4) (37.7) Properties sold 1.3 5.8 Acquisitions of businesses, less cash and short-term investments acquired (61.4) (11.3) Proceeds from sale of subsidiary - 36.1 Investing activities of discontinued operations (0.9) 6.5 Other (23.9) (5.3) ------- ------- Net cash provided (used) by investing activities 15.3 (86.3) ------- ------- (Continued) - 6 - McKESSON CORPORATION and SUBSIDIARIES STATEMENTS OF CONSOLIDATED CASH FLOWS Restated (unaudited) Six Months Ended September 30 ------------------ 1996 1995 ------ ------ (in millions) Financing Activities Proceeds from issuance of debt $ 95.4 $ 72.2 Repayment of debt (24.5) (4.7) Capital stock transactions Treasury stock acquired (145.2) (25.7) Issuances 6.6 3.8 ESOP notes and guarantee 2.4 2.2 Dividends paid (21.2) (21.8) Financing activities of discontinued operations 0.1 0.1 ------- ------- Net cash provided (used) by financing activities (86.4) 26.1 ------- ------- Net Decrease in Cash and Cash Equivalents (127.5) (34.1) Cash and Cash Equivalents at beginning of period 260.8 363.1 ------- ------- Cash and Cash Equivalents at end of period $ 133.3 $ 329.0 ======= ======= See Financial Notes. (Concluded) - 7 - McKESSON CORPORATION and SUBSIDIARIES FINANCIAL NOTES 1. Interim Financial Statements ---------------------------- In the opinion of the Company, these unaudited condensed consolidated financial statements include all adjustments necessary to a fair presentation of its financial position as of September 30, 1996 and the results of its operations and its cash flows for the six months ended September 30, 1996 and 1995. Such adjustments were of a normal recurring nature. Revenues and cost of sales have been restated to change the classification of sales and cost of sales associated with sales to customers' warehouses to present only the gross profit on such sales in revenues. The results of operations for the six months ended September 30, 1996 and 1995 are not necessarily indicative of the results for the full years. It is suggested that these interim financial statements be read in conjunction with the annual audited financial statements, accounting policies and financial notes thereto included in the Appendix to the Company's 1996 Proxy Statement which has previously been filed with the Securities and Exchange Commission. Such document was amended in February 1997 to reflect the discontinuance of Armor All Products Corporation ("Armor All") and Millbrook Distribution Services Inc. ("Service Merchandising"). 2. Acquisitions ------------ In April 1996, the Company acquired Automated Healthcare, Inc. ("AHI") for $61.4 million in cash and the assumption of $3.2 million of employee stock incentives. AHI designs, manufactures, sells and installs automated pharmaceutical dispensing equipment for use by health care institutions. The acquisition was accounted for as a purchase and accordingly, AHI's results are included in the consolidated financial statements since the date of acquisition. The results of operations of AHI were not material in relation to the Company's consolidated results of operations. The goodwill related to the acquisition of approximately $13.4 million is being amortized on a straight-line basis over a ten year period. A $48.2 million charge was recorded to write off the portion of the purchase price of AHI allocated to technology for which technological feasibility had not been established as of the acquisition date and for which there were no alternative uses. Existing technology was valued at $.4 million and is being amortized on a straight-line basis over a three year period. The Company utilized a discounted cash flow methodology by product line to value in-process and existing technologies as of the acquisition date. The resulting valuations represent management's best estimate of the respective fair values as of that date. As of the acquisition date, further costs necessary to develop the purchased technologies into commercially viable products were approximately $3.4 million, based on current estimates. Such costs are expected to be incurred during fiscal 1997 and 1998 and are associated with the following activities: engineering required to advance the design of products to the point that they meet specific functional and economic requirements and are ready for manufacture, prototype development, and product testing. The financial statements have been restated to reflect in the first quarter ended June 30, 1996, the $48.2 million charge to write off the portion of the purchase price of AHI allocated to technology for which feasibility had not been established as of the acquisition date of April 23, 1996. Such charge was recorded in the third quarter ended December 31, 1996 in the originally filed financial statements. The effects of the restatement on the financial statements as of and for the periods ended September 30, 1996 are as follows: As Previously Reported As Restated ---------------------- ----------- (in millions, except per share amounts) Total Assets $3,433.7 $3,385.5 Stockholders' Equity 977.9 929.7 Quarter Ended September 30, 1996: Net Income 28.1 28.1 Fully Diluted Earnings Per Share .64 .64 Six Months Ended September 30, 1996: Net Income 58.2 10.0 Fully Diluted Earnings Per Share 1.30 .22 - 8 - McKESSON CORPORATION and SUBSIDIARIES FINANCIAL NOTES 3. Discontinued Operations ----------------------- On December 31, 1996, the Company sold its 55% equity interest in Armor All to The Clorox Company for $221.9 million and recognized an after-tax gain of $120.2 million. In addition, in December 1996 the Company made the decision to divest the net assets of its Service Merchandising Division for which no loss on disposition is anticipated. All of the net assets and results of operations of both Armor All and Service Merchandising have been reclassified as discontinued operations for all periods presented. The net assets of discontinued operations at September 30, 1996 and March 31, 1996 were as follows: September 30 March 31 1996 1996 ------ ------ (in millions) Total assets $ 256.1 $ 275.5 Total liabilities (135.0) (149.8) ------ ------ Net assets $ 121.1 $ 125.7 ====== ====== Assets of discontinued operations consist primarily of cash, receivables, inventory, property plant and equipment, and goodwill of Armor All and Service Merchandising at September 30, 1996 and March 31, 1996. Liabilities of discontinued operations consist primarily of accounts payable and other accrued liabilities of Armor All and Service Merchandising at September 30, 1996 and March 31, 1996. The results of discontinued operations for the six months ended September 30, 1996 and 1995 were as follows: September 30 September 30 1996 1995 ------ ------ (in millions) Revenues $ 329.9 $ 380.2 ====== ====== Income from discontinued operations before taxes $ 15.7 $ 18.8 Provision for taxes on income (6.6) (7.6) Less: Minority interest (3.5) (2.9) ------ ------ Net income from discontinued operations $ 5.6 $ 8.3 ====== ====== Discontinued operations include $4.3 million and $3.5 million after-tax from the operations of Armor All and $1.3 million and $4.8 million after-tax from the operations of Service Merchandising for the six months ended September 30, 1996 and 1995, respectively. 4. Subsequent Event ---------------- On November 11, 1996, the Company announced the completion of its acquisition of the healthcare business of FoxMeyer Corporation ("FoxMeyer"), pursuant to an expedited auction process in the FoxMeyer bankruptcy proceeding in Wilmington, Delaware. The Company received regulatory clearance and court approval enabling the transaction to close on November 8, 1996. Through an amended sale agreement, the Company paid approximately $23 million in cash to the debtors, paid off approximately $500 million in secured debt and assumed an additional $75 million in other liabilities. The Company acquired assets consisting primarily of accounts receivable and inventories of approximately $650 million, customer contracts and fixed assets. The Company utilized proceeds from commercial paper issuances and a note payable to a bank to fund the transaction. The commercial paper issuances were backed by the Company's revolving credit agreements that were recently increased to provide borrowing availability of $500 million. - 9 - McKESSON CORPORATION and SUBSIDIARIES FINANCIAL REVIEW Segment Results - - --------------- The Company's Armor All and Service Merchandising segments have been classified as discontinued operations in the current quarter, and prior periods have been restated accordingly (see Financial Note 3). The revenues and operating profit of the Company's continuing operations by business segment are as follows: Three Months Ended Six Months Ended September 30 September 30 -------------------- -------------------- % % 1996 1995 Chg. 1996 1995 Chg. ------ ------ --- ------ ------ --- (in millions) REVENUES Health Care Services Direct Delivery U.S. (1) $2,272.4 $1,935.9 17.4 $4,491.9 $3,864.9 16.2 International 375.0 387.1 (3.1) 751.8 770.2 (2.4) ------- ------- ------- ------- Total Health Care Services 2,647.4 2,323.0 14.0 5,243.7 4,635.1 13.1 Water Products 77.6 74.1 4.7 148.0 138.1 7.2 Corporate 5.9 5.5 9.8 17.7 ------- ------- ------- ------- Total $2,730.9 $2,402.6 13.7 $5,401.5 $4,790.9 12.7 ======= ======= ======= ======= OPERATING PROFIT Health Care Serv.(2) $ 45.3 $ 45.1 0.4 $ 48.6 $ 94.0 (48.3) Water Products 14.4 13.6 5.9 24.0 22.5 6.7 ------ ------ ------ ------ Total 59.7 58.7 1.7 72.6 116.5 (37.7) Interest - net (3) (7.5) (2.2) (15.2) (4.8) Corporate and other (10.4) (10.1) (20.3) (18.3) ------ ------ ------ ------ Income before taxes $ 41.8 $ 46.4 (9.9) $ 37.1 $ 93.4 (60.3) ====== ====== ====== ====== (1) U.S. Health Care revenues reflect the reclassification of sales and cost of sales associated with sales to customers' warehouses and include only the gross margin on such sales in revenues. (2) Health Care Services operating profit for the six months ended September 30, 1996, includes a charge for $48.2 million to write off the portion of the purchase price of AHI allocated to technology for which feasibility had not been established as of the acquisition date. (3) Interest expense is shown net of corporate interest income. - 10 - McKESSON CORPORATION and SUBSIDIARIES FINANCIAL REVIEW Overview of Results - - ------------------- Net income for the second quarter decreased to $28.1 million, $.64 per fully-diluted share, from $31.7 million, $.68 per share in the prior year. For the six month period, net income decreased to $10.0 million, $.22 per share, from $64.5 million, $1.38 per share for the comparable period in the prior year. Results for the six month period include a $48.2 million charge to write off the portion of the purchase price of AHI allocated to technology for which feasibility had not been established as of the acquisition date. The results also included income from the discontinued Armor All and Service Merchandising segments of $2.3 million, $.05 per share and $3.5 million, $.07 per share in the second quarter and $5.6 million, $.12 per share, and $8.3 million, $.17 per share for the six month periods of fiscal 1997 and 1996, respectively. The increase in earnings in the Health Care Services segment (before the $48.2 million charge noted above), including costs associated with strategic initiatives, was more than offset by lower earnings from the discontinued Service Merchandising segment and higher net interest expense. The effective income tax rate applicable to continuing operations for the six months ended September 30, 1996 differed from the effective tax rate for the comparable period in fiscal 1996 primarily due to the write-off in the first quarter period of purchased in-process technology acquired with AHI of $48.2 million, which had no associated tax benefit. HEALTH CARE SERVICES The Health Care Services segment includes the operations of the Company's U.S. pharmaceutical and health care products distribution businesses and its international pharmaceutical operations (Canada and Mexico). This segment accounted for 97% of consolidated revenues for the second quarter and for the six month period ended September 30, 1996. Segment revenues increased by 14% and 13% for the three and six month periods, respectively, from the comparable periods in the prior year. U.S. Health Care revenue growth of 17% in the second quarter and 16% for the six month period was partially offset by declines in international sales. Year to year comparisons for international operations were affected by the sale of the Company's Central American pharmaceutical manufacturing operation in the second quarter of fiscal 1996. Operating profit for the quarter was flat with the prior year but decreased by 48.3% for the six month period. Excluding the effect of the $48.2 million charge noted above, operating profit increased by 3% for the six-month period. Results for the three and six month periods include $4.0 million and $8.2 million, respectively, of costs associated with a series of strategic initiatives designed to improve the Company's competitiveness in the retail and institutional market segments. These costs were partially offset by continued growth in the Company's U.S. Health Care business in every customer segment (independents, chain stores and hospitals) and operating expense efficiencies. The prior year second quarter results included a pretax gain of $11.2 million from the sale of the Central American operation. This gain was offset by research and development costs associated with retail and institutional initiatives and expenses incurred to further streamline operating and administrative functions. - 11 - McKESSON CORPORATION and SUBSIDIARIES FINANCIAL REVIEW WATER PRODUCTS Segment revenues increased by 5% and 7% for the three and six month periods, respectively, from the comparable periods in the prior year. Operating profit for the quarter increased by 6% and by 7% for the six month period. This improvement reflects sales growth in the direct delivery and grocery products businesses which have more than offset the costs of continuing geographic expansion into Washington and Texas. DISCONTINUED OPERATIONS The after tax results of the discontinued operations of Armor All and Service Merchandising decreased to $2.3 million in the quarter from $3.5 million in the second quarter of fiscal 1996, and to $5.6 million from $8.2 million in the comparable six month periods. Revenues of Armor All decreased by 6% for the quarter but increased 3% for the six month period, compared to the prior year primarily attributable to sales growth of Armor All Protectant and to sales of two new products introduced in December 1995. In the quarter, sales were down across all product lines. Pre-tax income increased by 23% in the quarter and six month period due primarily to a focus on controlling selling and marketing costs. Sales in the Service Merchandising segment decreased by 18% for both the three and six month periods from the comparable periods in the prior year. Strong competitive pressures and customer consolidations resulted in the loss of volume from several large customers in late fiscal 1996. Pre-tax income for the quarter decreased by 76% and by 70% for the six month period due primarily to the impact of fixed expenses over a lower revenue base. Liquidity and Capital Resources - - ------------------------------- Cash and cash equivalents decreased $127.5 million during the six months to $133.3 million primarily due to a temporary increase in certain customer receivable balances, stock repurchase activity, the cost of the acquisition referred to in Financial Note 2 and investments in technology associated with strategic initiatives. During the first six months of fiscal 1997, the Company repurchased 3.2 million shares of its common stock for $145 million under a share repurchase program initiated in June 1995 and expanded in May 1996. As of September 30, 1996, authorization to purchase up to an additional 2.4 million shares remained. The Company's debt-to-capital ratio increased from 31% at March 31, 1996 to 38% at September 30, 1996 largely as a result of short-term borrowings by its health care products distribution operations in Canada. On November 11, 1996, the Company announced the completion of the FoxMeyer acquisition referred to in Financial Note 4. - 12 - PART II. OTHER INFORMATION =========================== Item 6. Exhibits and Reports on Form 8-K - - ----------------------------------------- (a) Exhibits 27 Financial Data Schedule (b) Reports on Form 8-K 1. There were no reports on Form 8-K filed during the quarter ended September 30, 1996. 2. The following report on Form 8-K was filed October 9, 1996: Item 5. Other Events --------------------- The registrant announced that it had executed a definitive agreement to acquire substantially all of the assets of the healthcare distribution business of FoxMeyer Corporation. - 13 - SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. McKESSON CORPORATION (Registrant) Dated: June 6, 1997 By /s/ Richard H. Hawkins ---------------------------- Richard H. Hawkins Vice President and Chief Financial Officer By /s/ Heidi E. Yodowitz ---------------------------- Heidi E. Yodowitz Controller - 14 - EXHIBIT INDEX Exhibit Number Description - - ------- ----------- 27 Financial Data Schedule - 15 - EX-27 2
5 0000927653 MCKESSON 1,000 6-MOS MAR-31-1997 APR-01-1996 SEP-30-1996 133,300 57,000 977,300 44,300 1,283,800 2,433,300 746,900 380,200 3,385,500 1,803,600 439,500 0 0 400 929,300 3,385,500 5,401,500 5,401,500 4,938,600 5,364,400 0 3,600 21,100 37,100 32,700 4,400 5,600 0 0 10,000 0.22 0.22
-----END PRIVACY-ENHANCED MESSAGE-----